Before (n=212) | After (n=212) | P value† | |||
n | % | n | % | ||
Ability to diagnose and manage common opportunistic infections | 83 | 39.2 | 127 | 59.9 | <0.001 |
Ability to determine patients who are eligible for ART | 120 | 56.6 | 155 | 73.1 | <0.001 |
Ability to prescribe first-line ART regimens | 112 | 52.8 | 148 | 69.8 | <0.001 |
Ability to recognise and manage side effects of antiretroviral drugs | 92 | 43.4 | 134 | 63.2 | <0.001 |
Ability to diagnose and manage treatment failure | 89 | 42.0 | 129 | 60.8 | <0.001 |
Ability to interpret the results of viral load testing | 96 | 45.3 | 141 | 66.5 | <0.001 |
Ability to prescribe second-line ART regimens | 75 | 35.4 | 113 | 53.3 | <0.001 |
Ability to manage patients with HIV/hepatitis coinfection | 71 | 33.5 | 111 | 52.4 | <0.001 |
Ability to serve as the HIV expert in your district/province | 73 | 34.4 | 112 | 52.8 | <0.001 |
*Number and percentage of respondents who rated themselves ‘competent, very competent, or expert, teach other’ before and after joining a telehealth programme.
†McNemar test.
ART, antiretroviral therapy.